|
|
This is only a preview of the paper
Click here to register and get the full text.
Existing members click here to login
|
|
|
Genentech the leader on a new frontier, before 1976 biotechnology as an industry was unheard of, that is until Genentech was founded on April 7 1976. ... By the time the lunch had finished Genentech was the newest edition to Bay Area companies.
Genentech’s specific focus is of recombinant DNA. ... ” Genentech planned to create new medications for ailments previously incurable using non-DNA focused pharmaceutical techniques.
Genentech started with a little venture capital and tons ideas. ...
Genentech’s first success came only a year into opening their doors. ... These were important discoveries but the next one in 1979 put them over the top when Genentech scientists were able to clone the human growth hormone. ... The day of Genentech’s IPO the stalk ameadeatly went from 35 dollars a share to 88 dollars a share, one of the largest stalk run ups ever.
In 1982, Genentech marketed the first ever recombinant DNA drug, human insulin. ...
Genentech’s biggest success was yet to come. In 1985 Genentech received FDA approval to market Protropin® (somatrem for injection) growth hormone for children with growth hormone deficiency. ... To this day Protropin is still one of the leading products produced by Genentech. ... Do to there amazing success Genentech even went as far as to give uninsured patients free access to there human growth hormone products. Genentech was unbelievably successful and to the point that they were able to give back at the same time. ... A pharmaceutical company having such success as that of Genentech was unheard of. In 1988 Genentech was able to extended their uninsured program to include Activase.
Approximate Word count = 1296
Approximate Pages = 5.2
(250 words per page double spaced)
|
|
|
|
|
|